Home › Funds › PNC Financial Services › PRLD
PNC Financial Services position in PRLD
PRELUDE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)1.17K sh
Reported value held$6.24K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 64 | $244 | New |
| Q3 2024 | 64 | $132 | Hold |
| Q4 2024 | 64 | $82 | Hold |
| Q1 2025 | 1.19K | $915 | Add |
| Q2 2025 | 1.18K | $956 | Reduce |
| Q3 2025 | 1.17K | $1.69K | Reduce |
| Q4 2025 | 1.17K | $3.40K | Hold |
| Q1 2026 | 1.17K | $4.00K | Hold |
| Q2 2026 | 1.17K | $6.24K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRLD
- BlackRock Inc 1.80M sh · $9.58M · Q2 2026
- Two Sigma Investments 993.37K sh · $5.29M · Q2 2026
- Millennium Management 844.99K sh · $4.50M · Q2 2026
- Geode Capital Management 841.86K sh · $4.49M · Q2 2026
- Vanguard Group 1.41M sh · $4.10M · Q4 2025
- Morgan Stanley 503.86K sh · $2.69M · Q2 2026
- UBS Group AG 318.80K sh · $1.70M · Q2 2026
- Renaissance Technologies 281.20K sh · $1.50M · Q2 2026
- Northern Trust Corp 240.60K sh · $1.28M · Q2 2026
- Marshall Wace 190.69K sh · $1.02M · Q2 2026
- Goldman Sachs Group 120.83K sh · $644.04K · Q2 2026
- BNY Mellon 68.19K sh · $363.44K · Q2 2026